| A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy (NCT07227857) | Institut de Recherches Internationales Servier | 2025-11-24 |
| Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma (NCT06478212) | Institut de Recherches Internationales Servier | 2025-01-22 |
| Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation (NCT06501625) | Institut de Recherches Internationales Servier | 2024-12-16 |
| Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation (NCT06465953) | Institut de Recherches Internationales Servier | 2024-12-03 |
| Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas (NCT06225999) | Institut de Recherches Internationales Servier | 2024-04-25 |
| A Study of Vorasidenib in Participants With Moderate or Mild Hepatic Impairment and Matched Participants With Normal Hepatic Function (NCT05674474) | Institut de Recherches Internationales Servier | 2023-03-14 |
| Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma (NCT05484622) | Institut de Recherches Internationales Servier | 2023-01-20 |
| Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours (NCT05638334) | Institut de Recherches Internationales Servier | 2022-11-21 |
| Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal Cancer (NCT05223673) | Institut de Recherches Internationales Servier | 2022-04-21 |
| S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers (NCT05162755) | Institut de Recherches Internationales Servier | 2021-10-15 |
| Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia (NCT04591808) | Institut de Recherches Internationales Servier | 2021-09-09 |
| Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients (NCT04605978) | Institut de Recherches Internationales Servier | 2021-08-03 |
| SPARK-ALL: Calaspargase Pegol in Adults With ALL (NCT04817761) | Institut de Recherches Internationales Servier | 2021-07-07 |
| Clinical Investigation to Determine the Accuracy and Benefit of Cardioskin™ in Patients With Known Atrial Fibrillation (NCT03964025) | Institut de Recherches Internationales Servier | 2021-07-01 |
| A Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients With Acute Lymphoblastic Leukemia (ALL) (NCT04956666) | Institut de Recherches Internationales Servier | 2021-06-15 |
| A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19 (NCT02735083) | Institut de Recherches Internationales Servier | 2021-03-10 |
| Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia (NCT04742101) | Institut de Recherches Internationales Servier | 2021-03-10 |
| Phase I/II Trial of S64315 Plus Azacitidine in Acute Myeloid Leukaemia (NCT04629443) | Institut de Recherches Internationales Servier | 2021-02-17 |
| Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) (NCT04164901) | Institut de Recherches Internationales Servier | 2020-01-05 |
| A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia (NCT04067518) | Institut de Recherches Internationales Servier | 2019-10-17 |
| Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia (NCT03755154) | Institut de Recherches Internationales Servier | 2019-07-17 |
| Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension (NCT05820880) | Institut de Recherches Internationales Servier | 2019-05-06 |
| Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy. (NCT03869892) | Institut de Recherches Internationales Servier | 2019-03-21 |
| Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia. (NCT03672695) | Institut de Recherches Internationales Servier | 2018-11-28 |
| Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder. (NCT03715153) | Institut de Recherches Internationales Servier | 2018-10-04 |
| Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder (NCT03715166) | Institut de Recherches Internationales Servier | 2018-09-24 |
| Post Marketing Surveillance Study for ONIVYDE® in South Korea (NCT03446872) | Institut de Recherches Internationales Servier | 2018-03-08 |
| Safety of Single Intravenous Administration of S95010 in Human Healthy Volunteers (NCT03494712) | Institut de Recherches Internationales Servier | 2018-02-21 |
| S 81694 Plus Paclitaxel in Metastatic Breast Cancer (NCT03411161) | Institut de Recherches Internationales Servier | 2018-01-04 |